VANGUARD GROUP INC - 28 Nov 2025 SCHEDULE 13G/A Report for Amicus Therapeutics Inc Common Stock (FOLD)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Amicus Therapeutics Inc Common Stock
Symbol: FOLD
Shares outstanding: 308,713,740 shares
Disclosed Ownership: 30,871,374 shares
Ownership: 10%
Form type: SCHEDULE 13G/A
Filing time: 03 Dec 2025, 11:13:29 UTC
Date of event: 28 Nov 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	10%	30,871,374	0	2,120,104	Ashley Grim	Head of Global Fund Administration